"Prolactin and aggressive ER+ breast cancer"

At the conclusion of this activity, the participant will be able to:

1. Appreciate the epidemiologic evidence linking prolactin to the risk and progression of hormone receptor positive breast cancer
2. Understand some of the mechanisms whereby prolactin exposure outside of pregnancy can increase the risk for breast cancer
3. Understand how the tumor microenvironment may alter both prolactin and estrogen signals, pointing to the need for a better understanding of the diversity of prolactin actions in this disease

Medicine: Pathology
Linda A. Schuler, VMD, PHD, Dept. of Comparative Biosciences, University of Wisconsin-Madison
School of Medicine, VCU Alumni, VCU Faculty, VCU Health Care Providers, VCU Physicians, VCU Staff, VCU Students